Sign in
CompletedNo phase

Digitally Delivered Dietary Treament for Adult Patients With Irritable Bowel Syndrome: A Pilot Study

Key facts

Who runs it
Sahlgrenska University Hospital
Where
Sweden1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
32 people enrolled
Started
2 May 2024
Ended
1 Apr 2025
Type of study
Interventional
Treatments tested
  • Digital dietary platform
Record updated
28 May 2026

Who can take part

Age
18 years to 64 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Diagnosed with IBS (Rome IV) by physician
  • Age 18-64
  • Ability to read and understand Swedish
  • Signed informed consent

Who cannot take part

  • Received dietary treatmen for IBS previously
  • Manifestations of other conditions that may explain gastrointestinal symptoms
  • Manifestation of other serious medical conditions
  • Patients with ongoing eating disorders
  • Pregnant/lactating women

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Two carbohydrate reduced diets, the low FODMAP diet (LFD) and low-carbohydrate diet (LCD), have in randomized controlled studies shown efficacy in relieving symptoms in patients with Irritable Bowel Syndrome (IBS), but access to trained dieticians is limited. Digital delivery may offer a convenient, cost-effective and scalable solution. This pilot study aims to evaluate the effectiveness and feasibility of digitally delivered evidence-based dietary treatments in relieving gastrointestinal, psychological and somatic symptoms and improving quality of life in patients with IBS.

Read full original descriptionShow less

Adults with IBS will be recruited via social media and clinical referrals and will receive their choice of the two dietary treatments: LFD with traditional IBS dietary advice or LCD. Participants will get access to the digital platform which contains information about the study, IBS pathophysiology, the treatment diet along with recipes and a mobile application for food scanning. Participants will complete digital questionnaires at baseline and week four to evaluate changes in gastrointestinal symptoms (IBS-SSS), somatic and psychological symptoms (PHQ-15, HADS, VSI) and quality of life (IBS-QoL). Feasibility and adherence is assessed with an evaluation questionnaire.

The group in the trial

  • Digital delivery of low FODMAP diet or low-carbohydrate dietOther group

    Treatment: Digital dietary platform

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Digitally Delivered Dietary Treament for Irritable Bowel Syndrome
Record updated
28 May 2026